Back to today’s briefing

Story perspectives

FDA Unveils AI Tool Amid Job Cuts Concerns

6/5/2025

34 4

Summary

Story summary

The U.S. FDA is set to unveil Elsa, a cutting-edge generative AI tool, by June 30, 2025, aimed at streamlining clinical protocol assessments and safety evaluations while protecting sensitive data. However, this innovative launch comes amid substantial job cuts, raising concerns about its impact on regulatory operations and employee morale.

1 of 1

Story summary

The U.S. FDA is set to unveil Elsa, a cutting-edge generative AI tool, by June 30, 2025, aimed at streamlining clinical protocol assessments and safety evaluations while protecting sensitive data. However, this innovative launch comes amid substantial job cuts, raising concerns about its impact on regulatory operations and employee morale.